Hormone replacement therapy is associated with improved arterial physiology in healthy post-menopausal women

被引:110
作者
McCrohon, JA
Adams, MR
McCredie, RJ
Robinson, J
Pike, A
Abbey, M
Keech, AC
Celermajer, DS
机构
[1] UNIV SYDNEY, DEPT CARDIOL, ROYAL PRINCE ALFRED HOSP, CAMPERDOWN, NSW 2050, AUSTRALIA
[2] ROYAL PRINCE ALFRED HOSP, DEPT OBSTET & GYNAECOL, CAMPERDOWN, NSW 2050, AUSTRALIA
[3] HEART RES INST, CAMPERDOWN, NSW, AUSTRALIA
[4] CSIRO, DIV HUMAN NUTR, ADELAIDE, SA, AUSTRALIA
[5] UNIV SYDNEY, NATL HLTH & MED RES COUNCIL, CLIN TRIALS CTR, SYDNEY, NSW 2006, AUSTRALIA
关键词
D O I
10.1046/j.1365-2265.1996.8070816.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE Oestrogen replacement therapy is associated with a marked reduction in coronary event rates in post-menopausal women. As older age is associated with progressive arterial endothelial damage, a key event in atherosclerosis, we assessed whether hormone replacement therapy (HRT) with oestrogen alone, or oestrogen and progesterone combined, is associated with improved endothelial function in healthy women after the menopause. DESIGN Using high resolution external vascular ultrasound, brachial artery diameter was measured at rest and in response to reactive hyperaemia, with increased flow causing endothelium-dependent dilatation (flow-mediated dilatation). PATIENTS We investigated 135 healthy women; 40 were pre-menopausal (mean +/- SD age/26 +/- 6 years, group 1), 40 were post-menopausal and had never taken HRT (aged 58 +/- 3 years; group 2) and 55 were age-matched postmenopausal women who had taken HRT for greater than or equal to 2 years, from within 2 years of the menopause (aged 57 +/- 4 years; group 3). In group 3, 40 women were on combined oestrogen end progesterone and 15 on oestrogen-only HRT. RESULTS In group 2, flow-mediated dilatation was significantly reduced compared with group 1 (4.4 +/- 3.4 vs 9.6 +/- 3.6%, P < 0.001), consistent with a decline in arterial endothelial function after the menopause. In group 3, however, flow-mediated dilatation was significantly better than group 2 (6.2 +/- 3.3 vs 4.4 +/- 3.4%, P = 0.01), suggesting a protective effect of HRT. Flow-mediated dilatation was similar in women taking oestrogen alone and in those on combined HRT (5.5 +/- 2.8 vs 6.5 +/- 3.4%, P = 0.40). CONCLUSIONS Long-term HRT is associated with improved arterial endothelial function in healthy post-menopausal women. This benefit was observed in both the combined hormone replacement and unopposed oestrogen therapy groups. This may explain some of the apparent cardioprotective effect of HRT after the menopause.
引用
收藏
页码:435 / 441
页数:7
相关论文
共 50 条
  • [21] POST-MENOPAUSAL HORMONE REPLACEMENT THERAPY AND VAGINAL BLEEDING
    GREENBLATT, RB
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 249 (06): : 814 - 814
  • [22] Hormone replacement therapy is associated with increased systemic arterial compliance in post menopausal women.
    Rajkumar, C
    Mehra, R
    Kingwell, BA
    Komesaroff, P
    Sudhir, K
    Christophidis, N
    Jennings, GL
    Dart, AM
    Cameron, JD
    CIRCULATION, 1996, 94 (08) : 872 - 872
  • [23] HORMONE REPLACEMENT THERAPY IS ASSOCIATED WITH INCREASED RISK OF DEVELOPING COLONIC AND ANORECTAL DYSMOTILITY IN POST-MENOPAUSAL WOMEN
    Khalil, Jacqueline
    Song, Gengqing
    GASTROENTEROLOGY, 2024, 166 (05) : S1386 - S1386
  • [24] Hormone Replacement Therapy is Associated With Increased Risk of Developing Irritable Bowel Syndrome in Post-Menopausal Women
    Khalil, Jacqueline
    Sun, Yan
    Kaelber, David
    Lembo, Anthony J.
    Song, Gengqing
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S) : S547 - S547
  • [25] POST-MENOPAUSAL REPLACEMENT THERAPY
    BERDAH, J
    GAZETTE MEDICALE, 1989, 96 (04): : 37 - &
  • [26] Hormone Therapy in Peri- and Post-menopausal Women
    Lattrich, C.
    Ortmann, O.
    AUSTRIAN JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 2012, 5 (04): : 16 - 19
  • [27] Alterations in gallbladder emptying and bile lithogenicity in post-menopausal women on hormone replacement therapy
    Dhiman, RK
    Sarkar, PK
    Sharma, A
    Vasistha, K
    Kohli, KK
    Gupta, S
    Suri, S
    Chawla, Y
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09) : S60 - S60
  • [28] Plasma homocysteine and hormone replacement therapy in post-menopausal women with type 2 diabetes
    Buysschaert, M
    Hermans, MP
    DIABETES, 2002, 51 : A166 - A167
  • [29] The effects of hormone replacement therapy on plasma vitamin E levels in post-menopausal women
    Wu, JJ
    Norris, LA
    Wen, YC
    Sheppard, BL
    Feely, J
    Bonnar, J
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1996, 66 (02): : 151 - 154
  • [30] ESTROGEN REPLACEMENT THERAPY DOES NOT AFFECT MUSCLE CFLARACTERISTICS IN HEALTHY POST-MENOPAUSAL WOMEN
    Doyle, J.
    Ng, A. V.
    Sharoff, C.
    Beaudoin, F.
    Kent-Braun, J. A.
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2001, 33 (05) : S289 - S289